Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6HT0

Crystal structure of MLLT1 (ENL) YEATS domain in complexed with compound 94

Summary for 6HT0
Entry DOI10.2210/pdb6ht0/pdb
Related6HT1
DescriptorProtein ENL, SULFATE ION, 1,2-ETHANEDIOL, ... (5 entities in total)
Functional Keywordstranscription, yeats domain, enl, mllt1, chemical probe, inhibitor, structural genomics, structural genomics consortium, sgc
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight19319.19
Authors
Heidenreich, D.,Chaikuad, A.,Moustakim, M.,Arrowsmith, C.H.,Edwards, A.M.,Bountra, C.,Fedorov, O.,Brennan, P.E.,Knapp, S.,Structural Genomics Consortium (SGC) (deposition date: 2018-10-02, release date: 2018-10-17, Last modification date: 2024-01-24)
Primary citationMoustakim, M.,Christott, T.,Monteiro, O.P.,Bennett, J.,Giroud, C.,Ward, J.,Rogers, C.M.,Smith, P.,Panagakou, I.,Diaz-Saez, L.,Felce, S.L.,Gamble, V.,Gileadi, C.,Halidi, N.,Heidenreich, D.,Chaikuad, A.,Knapp, S.,Huber, K.V.M.,Farnie, G.,Heer, J.,Manevski, N.,Poda, G.,Al-Awar, R.,Dixon, D.J.,Brennan, P.E.,Fedorov, O.
Discovery of an MLLT1/3 YEATS Domain Chemical Probe.
Angew. Chem. Int. Ed. Engl., 57:16302-16307, 2018
Cited by
PubMed Abstract: YEATS domain (YD) containing proteins are an emerging class of epigenetic targets in drug discovery. Dysregulation of these modified lysine-binding proteins has been linked to the onset and progression of cancers. We herein report the discovery and characterisation of the first small-molecule chemical probe, SGC-iMLLT, for the YD of MLLT1 (ENL/YEATS1) and MLLT3 (AF9/YEATS3). SGC-iMLLT is a potent and selective inhibitor of MLLT1/3-histone interactions. Excellent selectivity over other human YD proteins (YEATS2/4) and bromodomains was observed. Furthermore, our probe displays cellular target engagement of MLLT1 and MLLT3. The first small-molecule X-ray co-crystal structures with the MLLT1 YD are also reported. This first-in-class probe molecule can be used to understand MLLT1/3-associated biology and the therapeutic potential of small-molecule YD inhibitors.
PubMed: 30288907
DOI: 10.1002/anie.201810617
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon